Advances in tuberculosis 2011-2012

Thorax

Volumn 68, Issue 3, 2013, Pages 283-287

  Zar, Heather J ^a   Udwadia, Zarir F ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE; ANTIRETROVIRUS AGENT; BCG VACCINE; DELAMANID; ETHIONAMIDE; ISONIAZID; LINEZOLID; MOXIFLOXACIN; PLACEBO; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAPENTINE;

BONE MARROW SUPPRESSION; CHILDHOOD DISEASE; CHILDHOOD TUBERCULOSIS; DRUG DOSE REDUCTION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FAINTNESS; HEART ARRHYTHMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LATENT TUBERCULOSIS; LIVER TOXICITY; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TRANSBRONCHIAL ASPIRATION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84873709825     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-203127     Document Type: Review

References (37)

1. World Health Organization (WHO). Global tuberculosis control report 2011. Geneva: WHO, 2011. http://www.who.int/tb/publications/global-report/2011/ (accessed 10 Dec 2012).
2. Udwadia ZF. MDR, XDR, TDR tuberculosis: ominous progression. Thorax 2012;67:286-8.
3. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012;366:2161-70.
4. Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet 2011;377:147-52.
5. Dalton T, Cegielski P, Akksilp S, et al. Prevalence and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet 2012;380:1406-17.
6. Ruan SY, Chuang CT, Wang JY, et al. Revisting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax 2012;67:822-7.
7. Navani N, Molyneaux PL, Breen RA, et al. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study. Thorax 2011;66:889-93.
8. Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40:442-7.
9. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011;184:132-40.
10. Seoudi N, Mitchell SL, Brown TJ, et al. Rapid molecular detection of tuberculosis and rifampicin drug resistance; retrospective analysis of a national UK molecular service over the last decade. Thorax 2012;67:361-7.
11. Sterling TR, Villarino E, Borisov AS, et al. Three months of rifapentene and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365:2155-66.
12. Samandari T, Agizew TB, Nyirendra S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomized, double-blind, placebo-controlled trial. Lancet 2011;377:2155-66.
13. Dharmadhikari AS, Mphahlele M, Stoltz A, et al. Surgical face masks worn by patients with multidrug-resistant tuberculosis. Impact on infectivity of air on a hospital ward. Am J Respir Crit Care Med 2012;185:1104-9.
14. Lee M, Lee J, Carroll MW, et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 2012;367:1508-18.
15. Sotgiu G, Centis R, D'Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 2012;40:1430-42.
16. Gler MT, Skripconoka V, Sanchez-Garavito E, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 2012;366:2151-60.
17. Diacon AH, Dawson R, von Groote-Bidlingmaier F, et al. 14-day bactericidal activity of PA-824, bedaqualine, pyrazinamide, and moxifloxacin combinations: a randomized trial. Lancet 2012;380:986-93.
18. Ahuja SD, Ashkin D, Avendano M, et al. Multidrug resistant pulmonary treatment regimens and treatment outcomes; an individual patient data meta-analysis of 9153 patients. PLoS Med 2012;9;8:e1001300.
19. World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update. Geneva: WHO. http://whqlibdoc.who.int/publications/2011/9789241501583-eng.pdf (accessed 8 Jan 2013).
20. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012;367:348-61.
21. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012;205 (Suppl 2):S199-208.
22. Hatherill M, Verver S, Mahomed H; Taskforce on Clinical Research Issues, Stop TB Partnership Working Group on TB Vaccines. Consensus statement on diagnostic end points for infant tuberculosis vaccine trials. Clin Infect Dis 2012;54:493-501.
23. World Health Organization (WHO). Use of tuberculosis interferon-gamma release assays (IGRAs) in low and middle-income countries: policy statement. Geneva: WHO, 2011.
24. Whittaker E, Zar HJ. Promising directions in the diagnosis of childhood tuberculosis. Expert Rev Respir Med 2012;6:385-95.
25. Moore A, Apolles P, de Villiers PJT, et al. Sputum induction for diagnosis of childhood pulmonary tuberculosis (PTB) in a community setting. Int J Tuberc Lung Dis 2011;15:1185-90.
26. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in hospitalized children in a high HIV-prevalence area. Lancet Infect Dis 2011;11:819-24.
27. Zar HJ, Workman L, Isaacs W, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 2012;55:1088-95.
28. Bates M, O'Grady J, Maeurer M, et al. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect Dis. Published Online First: 2 Nov 2012. doi: 10.1016/S1473-3099(12)70245-1
29. Faurholt-Jepsen D, Range N, PrayGod G, et al. BCG protects against tuberculosis irrespective of HIV status: a matched case-control study in Mwanza, Tanzania. Thorax. Published Online First: 24 Aug 2012. doi:10.1136/thoraxjnl- 2012-201971
30. Gomes VF, Andersen A, Wejse C, et al. Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau. Thorax 2011;66:163-7.
31. Mandalakas AM, Hesseling AC, Gie RP, et al. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2012. Published Online First: 20 June 2012. doi:10.1136/thoraxjnl-2011-200933
32. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007;334:136.
33. Frigati LJ, Kranzer K, Cotton MF, et al. The impact of isoniazid prophylaxis and antiretroviral therapy on tuberculosis in children infected with HIV in a high TB incidence setting. Thorax 2011;66:496-50.
34. Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011;365:21-31.
35. World Health Organization (WHO). WHO guidelines for intensified case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva: World Health Organization, 2011.
36. Chang KC, Leung CC, Grosset J, et al. Treatment of tuberculosis and optimal dosing schedules. Thorax 2011;66:997-1007.
37. Ettehad MDR, Schaaf HS, Seddon JA, et al. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:449-56.